Combined, these data are consistent with results using human CF macrophages and indicate that inhibition of MEK1/2 does not impact human or mouse macrophage or human neutrophil phagocytosis of opsonized microbes, phagosome maturation, or phagosome acidification. Here, MAP2K1 is linked to cystic fibrosis.